67469-02-7 Usage
Description
1,2-Benzenediamine, 4-(methylthio)-, also known as 2-Amino-4-(methylthio)aniline, is an organic compound with the molecular formula C7H10N2S. It is a derivative of benzenediamine, featuring a methylthio group (-SCH3) at the 4-position. 1,2-Benzenediamine, 4-(methylthio)is characterized by its reactivity and potential applications in various chemical and pharmaceutical processes.
Uses
Used in Pharmaceutical Industry:
1,2-Benzenediamine, 4-(methylthio)is used as an intermediate in the synthesis of metabolites for the pharmaceutical compound Albendazole (A511610). Albendazole is a widely used anthelmintic drug, effective against various parasitic worm infections. 1,2-Benzenediamine, 4-(methylthio)plays a crucial role in the production process, contributing to the development of this essential medication.
Check Digit Verification of cas no
The CAS Registry Mumber 67469-02-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,4,6 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 67469-02:
(7*6)+(6*7)+(5*4)+(4*6)+(3*9)+(2*0)+(1*2)=157
157 % 10 = 7
So 67469-02-7 is a valid CAS Registry Number.
67469-02-7Relevant articles and documents
NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
-
Page/Page column 44, (2009/12/05)
Substituted heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; Type 2 diabetes; insulin resistance; hyperglycemia; Metabolic Syndrome; neurological disease; cancer; and liver steatosis. Formula (I).
BENZIMIDAZOLE THIOPHENE COMPOUNDS
-
Page/Page column 212, (2008/06/13)
The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
